Skip to main content
Clinical Trials/IRCT201404123862N11
IRCT201404123862N11CompletedPhase 2

Evaluation the effect of platelets rich plasma on skin rejuvenation on elderly individuals

Mashhad University of Medical Sciences, Vice chancellor for research0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 55 years (—)
Sex
All

Inclusion Criteria

  • All volunteer individuals for wrinkle rejuvenating with scale II and III of Glogour; the patients did not use any local and systemic skin rejuvenation therapies six months before.
  • Exclusion criteria: pregnancy and breast feeding,Skin cancer; cancer of any part of the body and chemotherapy; Steroid therapyr; skin diseases with face involvement like porphyriar; patients with coagulation disorders; people who are taking aspirin with any other anticoagulant medicines; dialysis patients and patients with thrombocytopenia; smokers; alcoholics; malnourished individuals; people with the genetic skin problems; Advanced lesions due to sun exposure; advanced hyperpigmentation; capillary lesions on the nose and cheeks; patients who used vitamin A derivative; patients who don’t refer on follow up periods

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Mashhad University of Medical Sciences, Vice chancellor for research

Similar Trials